Literature DB >> 2516001

Mental status as a predictor of daily function in progressive dementia.

B R Reed, W J Jagust, J P Seab.   

Abstract

To evaluate a standardized mental status exam's ability to predict activities of daily living (ADLs), Mini Mental Status Exam (MMSE) scores and ADL scores were obtained from 59 patients with progressive dementias of widely varying severity but with no other psychiatric disorders or major medical problems. The MMSE scores explained only about one-third of the variance in both instrumental ADLs and physical ADLs in the whole sample, and the MMSE and ADLs were independent of one another in the less demented half of the sample. This suggests that cognitive losses and functional impairments are two distinct aspects of dementia severity, which must be assessed separately.

Entities:  

Mesh:

Year:  1989        PMID: 2516001     DOI: 10.1093/geront/29.6.804

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  14 in total

1.  Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce Reed; Mary N Haan; William J Jagust
Journal:  J Int Neuropsychol Soc       Date:  2004-05       Impact factor: 2.892

2.  Rate of Cognitive Decline Before and After the Onset of Functional Limitations in Older Persons.

Authors:  Kumar B Rajan; Liesi E Hebert; Paul A Scherr; Carlos F Mendes de Leon; Denis A Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-05-02       Impact factor: 6.053

3.  Relationship between executive functioning and activities of daily living in patients with relatively mild dementia.

Authors:  Jill Razani; Rachel Casas; Jennifer T Wong; Po Lu; Cathy Alessi; Karen Josephson
Journal:  Appl Neuropsychol       Date:  2007

4.  Aspects of Attention Predict Real-World Task Performance in Alzheimer's Disease.

Authors:  Beyon H Miloyan; Jill Razani; Andrea Larco; Justina Avila; Julia Chung
Journal:  Appl Neuropsychol Adult       Date:  2013-02-13       Impact factor: 2.248

5.  Slipping Anchor? Testing the Vignettes Approach to Identification and Correction of Reporting Heterogeneity.

Authors:  Teresa Bago d'Uva; Maarten Lindeboom; Owen O'Donnell; Eddy van Doorslaer
Journal:  J Hum Resour       Date:  2011

6.  Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

Authors:  Alexander Sun; Kyounghwa Bae; Elizabeth M Gore; Benjamin Movsas; Stuart J Wong; Christina A Meyers; James A Bonner; Steven E Schild; Laurie E Gaspar; Jeffery A Bogart; Maria Werner-Wasik; Hak Choy
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

7.  Association Between Executive Dysfunction and Instrumental Activities of Daily Living: Racial and Ethnic Differences Among Community-Dwelling Older Adults in the Southeastern US.

Authors:  Stephanie L Garrett; Richard E Kennedy; Patricia Sawyer; Courtney P Williams; Cynthia J Brown; Richard M Allman
Journal:  J Natl Med Assoc       Date:  2018-12-04       Impact factor: 1.798

Review 8.  Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment.

Authors:  Abhilash K Desai; George T Grossberg; Dharmesh N Sheth
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms.

Authors:  Elizabeth B Fauth; Sarah Schwartz; Joann T Tschanz; Truls Østbye; Christopher Corcoran; Maria C Norton
Journal:  Int J Geriatr Psychiatry       Date:  2012-09-12       Impact factor: 3.485

10.  Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study.

Authors:  H Agüero-Torres; L Fratiglioni; Z Guo; M Viitanen; E von Strauss; B Winblad
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.